Formel Skin Revenue and Competitors

Berlin, Germany

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Formel Skin's estimated annual revenue is currently $9.3M per year.(i)
  • Formel Skin's estimated revenue per employee is $126,000

Employee Data

  • Formel Skin has 74 Employees.(i)
  • Formel Skin grew their employee count by -9% last year.

Formel Skin's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
Cooperationsarzt bei FORMEL SkinReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M19-24%N/AN/A
#2
$18.3M13118%N/AN/A
#3
$1.6M190%N/AN/A
#4
$62.8M35911%N/AN/A
#5
$5.2M46-16%N/AN/A
#6
$14M100-7%N/AN/A
#7
$18.8M134-20%$70MN/A
#8
$2.5M268%N/AN/A
#9
$0.9M11-8%N/AN/A
#10
$12.5M8946%N/AN/A
Add Company

What Is Formel Skin?

FORMEL Skin offers medical and science-based solutions to effectively tackle a broad set of dermatological conditions (e.g. acne). The products are customized according to the medical needs and skin conditions of individuals after an online check-up with dermatologists. We are a passionate founder team with previous start-up experience and roots at The Boston Consulting Group, The Charité and Caroobi. We are well funded with significant investments from top tier VC funds Cherry Ventures, Heartcore Capital and well-known business angels. FORMEL Skin is now ready to unlock the next growth stage. We are looking for exceptional individuals that are willing to challenge themselves, and us, to join us on the journey to disrupt dermatology.

keywords:N/A

N/A

Total Funding

74

Number of Employees

$9.3M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Formel Skin News

2022-04-06 - Alemã Formel Skin chega ao Brasil com tratamento inovador para acne

... Semler e Anton Kononov, e criou a Formel Skin, startup que oferece um método personalizado para tratamento de acnes via telemedicina.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.7M741%N/A
#2
$11.3M74-5%$27M
#3
$11M744%N/A
#4
$13.7M7428%N/A
#5
$9.7M7440%N/A